Ligand Pharmaceuticals Incorporated
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Dec 2023 | 24.29x | $2.94 | $71.42 |
| Sep 2024 | 42.02x | $2.55 | $107.15 |
| Dec 2025 | 31.03x | $6.13 | $190.20 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Dec 2023 | 24.29x | $2.94 | $71.42 |
| Sep 2024 | 42.02x | $2.55 | $107.15 |
| Dec 2025 | 31.03x | $6.13 | $190.20 |